NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioAtlantis

BioAtlantis

Private
TraleeHealthcare & Life Scienceshttps://www.bioatlantis.com/

Last Round

Grant

Sep 1, 2023

Total Funding Raised

$1.38M

Company Overview

BioAtlantis is a biotechnology company that develops and manufactures natural biostimulants and bio-actives from seaweed for use in the crop, animal, and human health sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

plant biostimulantsseaweed extractagricultural biologicsagtechabiotic stress tolerancesustainable agriculturefeed supplementsseaweed extractionnutraceuticalsanimal gut healthagrochemical alternativescrop scienceorganic productiongood manufacturing practicesGMP+

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioAtlantis Comparables

Compare BioAtlantis with similar companies based on industry and business-model similarity.

BioAtlantis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brandon Bioscience
86%
Kelp Products International
83%
Acadian Seaplants
83%

BioAtlantis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2023
GrantJan 1, 2023
SeedJun 7, 2010

Key People

Founding team and executive leadership

Tom Paul Stack

CEO BioAtlantis México

Executive Team

BioAtlantis Investors

Notable investors and investment history

BioAtlantis investors
InvestorRounds
Kernel CapitalSeed
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 17, 2026

    Grew 22% QoQ, from 36 to 44 employees.

  • Nov 13, 2025

    Monthly visitors increased 45% MoM, reaching 2.5K.

BioAtlantis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioAtlantis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioAtlantis's valuation, stock price, and market status.

Firmographic Details

HeadquartersTralee
Employee Range44
Year Founded2004
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.